![Future Pharmacology | Free Full-Text | Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions Future Pharmacology | Free Full-Text | Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions](https://www.mdpi.com/futurepharmacol/futurepharmacol-03-00019/article_deploy/html/images/futurepharmacol-03-00019-g002.png)
Future Pharmacology | Free Full-Text | Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions
![Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study | Scientific Reports Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-74854-8/MediaObjects/41598_2020_74854_Fig1_HTML.png)
Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study | Scientific Reports
![ALBUTEROL SULFATE Inhalation Aerosol, with Dose Indicator FOR ORAL INHALATION ONLY Prescribing Information ALBUTEROL SULFATE Inhalation Aerosol, with Dose Indicator FOR ORAL INHALATION ONLY Prescribing Information](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=b46d1a78-607f-41dc-a432-c120e0fc6d59-02.jpg&id=544103)
ALBUTEROL SULFATE Inhalation Aerosol, with Dose Indicator FOR ORAL INHALATION ONLY Prescribing Information
![Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC today Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC today](https://today.uic.edu/wp-content/uploads/2022/02/medicine-6902841_1920-590x393.jpg)
Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC today
![Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial - The Lancet Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2066710324/2066792431/gr1.gif)